190 related articles for article (PubMed ID: 37548445)
21. Inflammatory Bowel Disease-Associated Colorectal Cancer Epidemiology and Outcomes: An English Population-Based Study.
Birch RJ; Burr N; Subramanian V; Tiernan JP; Hull MA; Finan P; Rose A; Rutter M; Valori R; Downing A; Morris EJA
Am J Gastroenterol; 2022 Nov; 117(11):1858-1870. PubMed ID: 36327438
[TBL] [Abstract][Full Text] [Related]
22. [Surveillance of patients with inflammatory bowel diseases].
Moshkowitz M; Kariv R; Half B; Vilkin A; Levi Z; Niv Y; Dotan I;
Harefuah; 2011 Apr; 150(4):389-91, 417. PubMed ID: 22164923
[TBL] [Abstract][Full Text] [Related]
23. Reduction of colorectal cancer risk in patients with Crohn's disease.
Lichtenstein GR
Rev Gastroenterol Disord; 2002; 2 Suppl 2():S16-24. PubMed ID: 12478240
[TBL] [Abstract][Full Text] [Related]
24. Hereditary Colorectal Cancer Syndromes and Inflammatory Bowel Diseases: an ECCO CONFER Multicentre Case Series.
Barberio B; Savarino E; Verstockt B; Fumery M; Pugliese D; Bertani L; Buda A; Dragoni G; Goren I; Laish I; Spinelli A; Teich N; Truyens M; Ellul P
J Crohns Colitis; 2022 Dec; 16(12):1845-1852. PubMed ID: 35771951
[TBL] [Abstract][Full Text] [Related]
25. Interval colorectal cancers in inflammatory bowel disease: the grim statistics and true stories.
Sanduleanu S; Rutter MD
Gastrointest Endosc Clin N Am; 2014 Jul; 24(3):337-48. PubMed ID: 24975525
[TBL] [Abstract][Full Text] [Related]
26. Colorectal Cancer Screening in Inflammatory Bowel Disease.
Sengupta N; Yee E; Feuerstein JD
Dig Dis Sci; 2016 Apr; 61(4):980-9. PubMed ID: 26646250
[TBL] [Abstract][Full Text] [Related]
27. Patients Prioritize a Low-volume Bowel Preparation in Colitis-associated Colorectal Cancer Surveillance: A Discrete Choice Experiment.
Wijnands AM; Te Groen M; Peters Y; Kaptein AA; Oldenburg B; Hoentjen F; Lutgens MWMD
Inflamm Bowel Dis; 2022 Jul; 28(7):1053-1060. PubMed ID: 34487155
[TBL] [Abstract][Full Text] [Related]
28. Chromoendoscopy for Surveillance in Inflammatory Bowel Disease Does Not Increase Neoplasia Detection Compared With Conventional Colonoscopy With Random Biopsies: Results From a Large Retrospective Study.
Mooiweer E; van der Meulen-de Jong AE; Ponsioen CY; Fidder HH; Siersema PD; Dekker E; Oldenburg B
Am J Gastroenterol; 2015 Jul; 110(7):1014-21. PubMed ID: 25823770
[TBL] [Abstract][Full Text] [Related]
29. Occurrence of Colorectal Cancer and the Influence of Medical Treatment in Patients With Inflammatory Bowel Disease: A Danish Nationwide Cohort Study, 1997 to 2015.
Weimers P; Ankersen DV; Løkkegaard ECL; Burisch J; Munkholm P
Inflamm Bowel Dis; 2021 Oct; 27(11):1795-1803. PubMed ID: 33409534
[TBL] [Abstract][Full Text] [Related]
30. Strategies for detecting colon cancer in patients with inflammatory bowel disease.
Bye WA; Nguyen TM; Parker CE; Jairath V; East JE
Cochrane Database Syst Rev; 2017 Sep; 9(9):CD000279. PubMed ID: 28922695
[TBL] [Abstract][Full Text] [Related]
31. Increased Colorectal Neoplasia Risk in Patients with Inflammatory Bowel Disease and Serrated Polyps with Dysplasia.
de Jong ME; Nagtegaal ID; Vos S; van der Post RS; van Herwaarden Y; Derikx LAAP; Hoentjen F
Dig Dis Sci; 2022 Dec; 67(12):5647-5656. PubMed ID: 35380348
[TBL] [Abstract][Full Text] [Related]
32. Adherence to endoscopic surveillance for advanced lesions and colorectal cancer in inflammatory bowel disease: an AEG and GETECCU collaborative cohort study.
Ballester MP; Mesonero F; Flórez-Diez P; Gómez C; Fuentes-Valenzuela E; Martín N; Senosiain C; Vela M; Fernández-Clotet A; Pérez P; Rubín de Célix C; Calviño-Suárez C; Hermida B; Muñoz R; González-Vivo M; Brunet E; Jiménez N; Botella B; Yebra J; Suárez-Ferrer C; Bouhmidi A; López-Serrano A; Ponferrada Á; Dueñas C; Mínguez M;
Aliment Pharmacol Ther; 2022 Jun; 55(11):1402-1413. PubMed ID: 35224758
[TBL] [Abstract][Full Text] [Related]
33. Declining risk of colorectal cancer in inflammatory bowel disease: an updated meta-analysis of population-based cohort studies.
Lutgens MW; van Oijen MG; van der Heijden GJ; Vleggaar FP; Siersema PD; Oldenburg B
Inflamm Bowel Dis; 2013; 19(4):789-99. PubMed ID: 23448792
[TBL] [Abstract][Full Text] [Related]
34. Colorectal Strictures in Patients With Inflammatory Bowel Disease Do Not Independently Predict Colorectal Neoplasia.
Axelrad JE; Faye A; Slaughter JC; Harpaz N; Itzkowitz SH; Shah SC
Inflamm Bowel Dis; 2022 Jun; 28(6):855-861. PubMed ID: 34319381
[TBL] [Abstract][Full Text] [Related]
35. Strategies for Detecting Colorectal Cancer in Patients with Inflammatory Bowel Disease: A Cochrane Systematic Review and Meta-Analysis.
Bye WA; Ma C; Nguyen TM; Parker CE; Jairath V; East JE
Am J Gastroenterol; 2018 Dec; 113(12):1801-1809. PubMed ID: 30353058
[TBL] [Abstract][Full Text] [Related]
36. Strategies for detecting colon cancer and/or dysplasia in patients with inflammatory bowel disease.
Mpofu C; Watson AJ; Rhodes JM
Cochrane Database Syst Rev; 2004; (2):CD000279. PubMed ID: 15106148
[TBL] [Abstract][Full Text] [Related]
37. Colitis-associated colorectal cancer in patients with inflammatory bowel disease.
Baek SJ; Kim SH
Minerva Chir; 2017 Dec; 72(6):520-529. PubMed ID: 29072418
[TBL] [Abstract][Full Text] [Related]
38. Inflammatory bowel disease as a risk factor for colorectal cancer.
Lukas M
Dig Dis; 2010; 28(4-5):619-24. PubMed ID: 21088413
[TBL] [Abstract][Full Text] [Related]
39. Rate of early/missed colorectal cancers after colonoscopy in older patients with or without inflammatory bowel disease in the United States.
Wang YR; Cangemi JR; Loftus EV; Picco MF
Am J Gastroenterol; 2013 Mar; 108(3):444-9. PubMed ID: 23295277
[TBL] [Abstract][Full Text] [Related]
40. The risk of colorectal cancer in inflammatory bowel disease: a hospital-based cohort study from Korea.
Lee HS; Park SH; Yang SK; Ye BD; Kim JH; Kim SO; Soh JS; Lee S; Bae JH; Lee HJ; Yang DH; Kim KJ; Byeon JS; Myung SJ; Yoon YS; Yu CS; Kim JH
Scand J Gastroenterol; 2015 Feb; 50(2):188-96. PubMed ID: 25515241
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
